Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 411–420 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 411
- Medicine slug
- dexmethylphenidate
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 40
- Source count
- 40
- Agreement rate
- 0.625
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 25
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 25 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abe6862b-3cf3-4aad-98ea-05a5fb54ebec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c450fa-c8c5-4ff0-a263-4a9eee6f5437 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7410d65-9c7f-4ffd-b957-969e2725f38f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e304388e-86a6-4335-abae-0ce79c7c99c6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ed9f3c8-c71f-499e-bb91-c19847bf4444 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd659d39-41f5-4612-8f17-bad602b4784d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a03d8819-a315-4337-ac50-530af98082b0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb4f32eb-05c7-449e-8e5a-f45781a58f70 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06bcef7a-b321-4dd8-9bf6-5d8f8940f04a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0133bf5-3cb3-4405-a007-43fbcf957333 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:424da264-7448-4364-939f-d3ebbee1a6d7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93e56455-0f15-4ed9-a63a-7fbd0697d520 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77659abe-74be-4092-90fe-cc475726d4ec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b82e8d08-cc4a-40a6-85a5-07717f3cb38b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a1da905-42a0-4748-9c39-67eca45deccc (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b64f3622-b3d7-4a1e-9f1f-0ac0fe3dadfe (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edad7c67-a872-41ad-a8bd-169278693cc2 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32b3c189-f0f8-4f3e-87da-ce56f583fc42 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf76f62-48aa-4065-94fd-6fc910391ab5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9700cc3d-52e9-40e4-8595-f1c56279a2e0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72d7a084-79cf-44c5-a158-fae1fc2faba4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6593b3ae-efcc-49ff-ba51-3fb5558605e5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3318fec-a1bc-4e3c-86a9-3f00ec296869 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c423a632-e8e0-44a7-a8a8-f66cec81aa64 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was about 3 hours in healthy adults.
2.2 hours
- Numeric value
- 2.2
- Unit
- hours
- Source records
- 15
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 15 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f930af78-760b-42c7-af30-ffcc64c4d35d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c717ae4-ec27-47db-ac1b-e504dbb379be (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a61932ef-c2b6-4363-a21d-1f0358f317b6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17950616-ab96-4d7e-be48-f36cae547de0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f2aa66a-51dc-459c-a765-5364bccd310f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f65759db-5294-4e82-bb3c-3ea368edaca7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:830df993-db01-40df-beef-90af6b86f561 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:638f614c-bf91-4bf6-876f-bf25fa273bc4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2016f5c2-95d2-4655-af65-c588c2bf5e6d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:194bb3a5-5f6c-49e3-85ab-ac557b3f8bbd (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f88da72d-c22f-413b-9dce-60871299b06a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76aa2130-2b7b-40f7-a35a-d51b21da4636 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90308fd0-d174-4979-aa22-16290d6cc5bb (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:987b4983-1edc-40f1-adc9-724747080969 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea04c0e3-0be3-4607-bd59-29f611e6681b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The mean terminal elimination half-life of dexmethylphenidate was approximately 2.2 hours.
Projected row 412
- Medicine slug
- dexmethylphenidate
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 40
- Source count
- 40
- Agreement rate
- 1
- Recorded readings
12%
- Numeric value
- 12
- Unit
- %
- Source records
- 40
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 40 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abe6862b-3cf3-4aad-98ea-05a5fb54ebec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f930af78-760b-42c7-af30-ffcc64c4d35d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c450fa-c8c5-4ff0-a263-4a9eee6f5437 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7410d65-9c7f-4ffd-b957-969e2725f38f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c717ae4-ec27-47db-ac1b-e504dbb379be (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e304388e-86a6-4335-abae-0ce79c7c99c6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ed9f3c8-c71f-499e-bb91-c19847bf4444 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd659d39-41f5-4612-8f17-bad602b4784d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a61932ef-c2b6-4363-a21d-1f0358f317b6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17950616-ab96-4d7e-be48-f36cae547de0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a03d8819-a315-4337-ac50-530af98082b0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb4f32eb-05c7-449e-8e5a-f45781a58f70 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06bcef7a-b321-4dd8-9bf6-5d8f8940f04a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f2aa66a-51dc-459c-a765-5364bccd310f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0133bf5-3cb3-4405-a007-43fbcf957333 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f65759db-5294-4e82-bb3c-3ea368edaca7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:830df993-db01-40df-beef-90af6b86f561 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:424da264-7448-4364-939f-d3ebbee1a6d7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:638f614c-bf91-4bf6-876f-bf25fa273bc4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93e56455-0f15-4ed9-a63a-7fbd0697d520 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2016f5c2-95d2-4655-af65-c588c2bf5e6d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77659abe-74be-4092-90fe-cc475726d4ec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:194bb3a5-5f6c-49e3-85ab-ac557b3f8bbd (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f88da72d-c22f-413b-9dce-60871299b06a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b82e8d08-cc4a-40a6-85a5-07717f3cb38b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a1da905-42a0-4748-9c39-67eca45deccc (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b64f3622-b3d7-4a1e-9f1f-0ac0fe3dadfe (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edad7c67-a872-41ad-a8bd-169278693cc2 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76aa2130-2b7b-40f7-a35a-d51b21da4636 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32b3c189-f0f8-4f3e-87da-ce56f583fc42 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf76f62-48aa-4065-94fd-6fc910391ab5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90308fd0-d174-4979-aa22-16290d6cc5bb (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:987b4983-1edc-40f1-adc9-724747080969 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea04c0e3-0be3-4607-bd59-29f611e6681b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9700cc3d-52e9-40e4-8595-f1c56279a2e0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72d7a084-79cf-44c5-a158-fae1fc2faba4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6593b3ae-efcc-49ff-ba51-3fb5558605e5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3318fec-a1bc-4e3c-86a9-3f00ec296869 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c423a632-e8e0-44a7-a8a8-f66cec81aa64 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of dexmethylphenidate is not known; racemic methylphenidate is bound to plasma proteins by 12% to 15%, independent of concentration.
Projected row 413
- Medicine slug
- dexmethylphenidate
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 40
- Source count
- 25
- Agreement rate
- 1
- Recorded readings
1.5 hours
- Numeric value
- 1.5
- Unit
- hours
- Source records
- 25
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 25 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abe6862b-3cf3-4aad-98ea-05a5fb54ebec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules are similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c450fa-c8c5-4ff0-a263-4a9eee6f5437 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7410d65-9c7f-4ffd-b957-969e2725f38f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e304388e-86a6-4335-abae-0ce79c7c99c6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ed9f3c8-c71f-499e-bb91-c19847bf4444 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd659d39-41f5-4612-8f17-bad602b4784d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of Focalin tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a03d8819-a315-4337-ac50-530af98082b0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb4f32eb-05c7-449e-8e5a-f45781a58f70 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06bcef7a-b321-4dd8-9bf6-5d8f8940f04a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0133bf5-3cb3-4405-a007-43fbcf957333 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:424da264-7448-4364-939f-d3ebbee1a6d7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93e56455-0f15-4ed9-a63a-7fbd0697d520 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77659abe-74be-4092-90fe-cc475726d4ec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b82e8d08-cc4a-40a6-85a5-07717f3cb38b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a1da905-42a0-4748-9c39-67eca45deccc (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for Focalin XR is similar to that of Focalin tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b64f3622-b3d7-4a1e-9f1f-0ac0fe3dadfe (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edad7c67-a872-41ad-a8bd-169278693cc2 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate HCl extended-release capsules is similar to that of dexmethylphenidate HCl immediate release tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32b3c189-f0f8-4f3e-87da-ce56f583fc42 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf76f62-48aa-4065-94fd-6fc910391ab5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for Focalin XR is similar to that of Focalin tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9700cc3d-52e9-40e4-8595-f1c56279a2e0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72d7a084-79cf-44c5-a158-fae1fc2faba4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release capsules is similar to that of dexmethylphenidate hydrochloride tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6593b3ae-efcc-49ff-ba51-3fb5558605e5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3318fec-a1bc-4e3c-86a9-3f00ec296869 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c423a632-e8e0-44a7-a8a8-f66cec81aa64 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
The initial rate of absorption for dexmethylphenidate hydrochloride extended-release is similar to that of dexmethylphenidate tablets as shown by the similar rate parameters between the 2 formulations, i.e., first peak concentration (C max1 ), and time to the first peak (t max1 ), which is reached in 1.5 hours (typical range 1 to 4 hours).
Projected row 414
- Medicine slug
- dexmethylphenidate
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 40
- Source count
- 37
- Agreement rate
- 1
- Recorded readings
2.65 ± 1.11 L/kg
- Numeric value
- 2.65
- Unit
- L/kg
- Source records
- 37
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 37 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abe6862b-3cf3-4aad-98ea-05a5fb54ebec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f930af78-760b-42c7-af30-ffcc64c4d35d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9c450fa-c8c5-4ff0-a263-4a9eee6f5437 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7410d65-9c7f-4ffd-b957-969e2725f38f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c717ae4-ec27-47db-ac1b-e504dbb379be (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e304388e-86a6-4335-abae-0ce79c7c99c6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ed9f3c8-c71f-499e-bb91-c19847bf4444 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd659d39-41f5-4612-8f17-bad602b4784d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a61932ef-c2b6-4363-a21d-1f0358f317b6 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17950616-ab96-4d7e-be48-f36cae547de0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a03d8819-a315-4337-ac50-530af98082b0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb4f32eb-05c7-449e-8e5a-f45781a58f70 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06bcef7a-b321-4dd8-9bf6-5d8f8940f04a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f2aa66a-51dc-459c-a765-5364bccd310f (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0133bf5-3cb3-4405-a007-43fbcf957333 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f65759db-5294-4e82-bb3c-3ea368edaca7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:830df993-db01-40df-beef-90af6b86f561 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:424da264-7448-4364-939f-d3ebbee1a6d7 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93e56455-0f15-4ed9-a63a-7fbd0697d520 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2016f5c2-95d2-4655-af65-c588c2bf5e6d (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77659abe-74be-4092-90fe-cc475726d4ec (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:194bb3a5-5f6c-49e3-85ab-ac557b3f8bbd (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f88da72d-c22f-413b-9dce-60871299b06a (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b82e8d08-cc4a-40a6-85a5-07717f3cb38b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a1da905-42a0-4748-9c39-67eca45deccc (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b64f3622-b3d7-4a1e-9f1f-0ac0fe3dadfe (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edad7c67-a872-41ad-a8bd-169278693cc2 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32b3c189-f0f8-4f3e-87da-ce56f583fc42 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf76f62-48aa-4065-94fd-6fc910391ab5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:987b4983-1edc-40f1-adc9-724747080969 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea04c0e3-0be3-4607-bd59-29f611e6681b (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9700cc3d-52e9-40e4-8595-f1c56279a2e0 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72d7a084-79cf-44c5-a158-fae1fc2faba4 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6593b3ae-efcc-49ff-ba51-3fb5558605e5 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3318fec-a1bc-4e3c-86a9-3f00ec296869 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c423a632-e8e0-44a7-a8a8-f66cec81aa64 (opens source in a new tab)
Dexmethylphenidate label
Version not recorded · Effective date not recorded
Dexmethylphenidate shows a volume of distribution of 2.65 ± 1.11 L/kg.
Projected row 415
- Medicine slug
- dexrazoxane
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
22.4 L
- Numeric value
- 22.4
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68089182-d4a2-4053-8d0d-fc97a901515d (opens source in a new tab)
Dexrazoxane label
Version not recorded · Effective date not recorded
The estimated mean steady-state volume of distribution of dexrazoxane is 22.4 L/m 2 after 500 mg/m 2 of dexrazoxane for injection dose followed by 50 mg/m 2 of doxorubicin, suggesting distribution throughout total body water (25 L/m 2 ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7c01089-85f5-40aa-b679-f53a425b4d68 (opens source in a new tab)
Dexrazoxane label
Version not recorded · Effective date not recorded
The estimated mean steady-state volume of distribution of dexrazoxane is 22.4 L/m 2 after 500 mg/m 2 of dexrazoxane dose followed by 50 mg/m 2 of doxorubicin, suggesting distribution throughout total body water (25 L/m 2 ).
Projected row 416
- Medicine slug
- dextroamphetamine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 28
- Source count
- 5
- Agreement rate
- 0.8
- Recorded readings
11.75 hours
- Numeric value
- 11.75
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76da9845-2ce1-49a5-9bf3-6a550d623172 (opens source in a new tab)
Dextroamphetamine label
Version not recorded · Effective date not recorded
The half-life was 11.75 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7658071e-ee2c-4d23-94ce-1906959ec036 (opens source in a new tab)
Dextroamphetamine label
Version not recorded · Effective date not recorded
The half-life was 11.75 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1548cce2-fb6b-4f17-8a3b-868933f6c9d6 (opens source in a new tab)
Dextroamphetamine label
Version not recorded · Effective date not recorded
The half-life was 11.75 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94674695-aa8a-3150-e053-2995a90a445f (opens source in a new tab)
Dextroamphetamine label
Version not recorded · Effective date not recorded
The half-life was 11.75 hours.
6.4 to 11.5 hours
- Numeric value
- 6.4
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0862f02a-72a8-41cc-8845-57cf4974bb6f (opens source in a new tab)
Dextroamphetamine label
Version not recorded · Effective date not recorded
Elimination When XELSTRYM is removed after 9 hours wear time, the mean apparent elimination half-life of dextroamphetamine ranged from 6.4 to 11.5 hours in the pediatric and adult population, respectively.
Projected row 417
- Medicine slug
- diazepam
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 89
- Source count
- 5
- Agreement rate
- 0.8
- Recorded readings
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1b2848b-b265-4f6f-9141-bf106dec0726 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The absolute bioavailability of diazepam rectal gel relative to Valium injectable is 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:652714c7-25c4-4d05-979d-8eee3b6f2f4d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The absolute bioavailability of diazepam rectal gel relative to Valium injectable is 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d99b68aa-b3dc-49c8-8894-3da255cd26b0 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The absolute bioavailability of diazepam rectal gel relative to Valium injectable is 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5b17a28-2cab-4c0d-8f9d-7b224e4d0989 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The absolute bioavailability of diazepam rectal gel relative to Valium injectable is 90%.
97%
- Numeric value
- 97
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a8bcc90-68fa-474d-832c-0df01e825f39 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The absolute bioavailability of VALTOCO relative to intravenous diazepam was 97%.
Projected row 418
- Medicine slug
- diazepam
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 89
- Source count
- 66
- Agreement rate
- 0.924242
- Recorded readings
1 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 61
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 61 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:078bbb41-7e3a-48db-87f0-ec6a6ec0194e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8d26f65-a015-4bfc-b1fa-8595d72af48c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9424ce71-f04c-4d70-89de-b7858931c53d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22688087-27ad-620c-e063-6394a90a134c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b326c66d-5762-4d16-933c-619fa2088ccd (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2768add-5e01-4ff4-afa3-230380d59a1f (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01f04ee4-fff9-499a-8213-984e16368084 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ebef149-1858-4199-aaed-7b9341fae63d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32e7bfa1-6060-4041-a0e5-249cacb84ebc (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec433be5-d84d-425f-9edf-71263f885eec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8e4d5f5-3b4c-4c0f-a818-9da86389473c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2fc6f38-d627-4fb3-9be2-5e119ee7e1e1 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e85abed-1a8b-4762-a31f-f2c7f196b8af (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba953b22-f0cd-4be5-9e0e-178bded88727 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:83c1f93b-0fc6-4512-9c8f-9167b217d7f9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:632d7e96-d32c-45b8-86cf-f18ec2b35485 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b47dc708-e83b-4224-bdb5-c9b7abd35cfb (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b51f4b3-a5e8-4400-b624-ac0c47630c86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7646785b-dabc-482d-bf42-06177f00aca2 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dcbb5e9-1e8f-4069-9244-adb46356714d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04cc10ad-7d5c-434e-9b29-85b14071492b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87b0fbb9-0c05-4ab0-8efe-7ffcae85b868 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78d5a77d-5ca7-4f16-b4d0-fce86456593c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84cecab3-d0e6-436b-996b-0b598e972308 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ad84940-40f7-457a-8ffa-53e1a7bfee16 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:181cc7ac-5129-2200-e063-6394a90afd3a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c397a9da-862f-4f3f-8109-7d21691de53a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7a4b3c7-7021-4764-8c21-49e4bc6f6058 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9322b0bc-e9fa-4c89-808b-110decf6db58 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b29916fb-1781-4112-9c3e-45478754d638 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f799120-0d08-47cd-8183-a98f0267c845 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:167ee280-be68-4a28-a7d8-de41df14bc48 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114ae6e-8cae-e96f-e063-6294a90a9e60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48aa32cb-047a-414a-822e-82a5f26d8817 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb839fb-27e5-4a11-aed6-da0a7ab6e996 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdb8feda-01c6-45bd-bd66-97196ccce70c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823093aa-d0cd-53c9-e053-2a91aa0a5235 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cb19468-be02-4219-9e80-94a28e2317b9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5111654f-a026-71b2-e063-6294a90ab49b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426f3da1-4105-ba0a-e063-6294a90a7a86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6abedac6-5133-47b2-a0e3-e239e0a2254b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2483426d-3782-432a-8b8d-86c06ef0de4a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20e08b97-bb89-4129-a228-8ad9cf35a1d3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7542d46-2586-4225-b07d-2633116bfa0a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf031ae-d59b-430d-9b15-415ae2e49c98 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b3cc5c9-91bd-7467-e053-2a95a90a44b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:859461ea-5861-8185-e053-2991aa0a954a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:547c2ad4-113c-7771-e063-6394a90a2073 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32c3af91-a57a-1278-e063-6294a90ae5ec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeadf0b0-918b-40e0-a5e8-60b2fcbd5ded (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b4946b3-ae6c-4174-bbd8-0b8ed2c8fdf3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9a7906-4dca-4c1f-b16b-9b666a86b363 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b24f1eb7-3dab-4183-b81f-f86ac62aedd8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2047f721-6a05-c391-e063-6394a90a4ed7 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b0c9c0a-4274-4d56-a7a4-bc497916469c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:260e2041-2bb3-482f-850e-b5d47a7bdbe6 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:554baee5-b171-4452-a50a-41a0946f956c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ac0b9d-d4ad-4aaa-8bee-902365f4e9a8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21785bb2-cc96-7973-e063-6294a90ab1b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7002d26-3856-4c2f-e053-2995a90aea60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to >3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d322c6a-7f7e-1cc4-e063-6294a90a8e2e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
The initial distribution phase has a half-life of approximately 1 hour, although it may range up to > 3 hours.
15 hours
- Numeric value
- 15
- Unit
- hours
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a8bcc90-68fa-474d-832c-0df01e825f39 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Specific Populations Geriatric Patients A study of single dose IV administration of diazepam (0.1 mg/kg) indicates that the elimination half-life of diazepam increases linearly with age, ranging from about 15 hours at 18 years (healthy young adults) to about 100 hours at 95 years (healthy elderly) with a corresponding decrease in clearance of free diazepam [see Use in Specific Populations (8.5) ].
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1b2848b-b265-4f6f-9141-bf106dec0726 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Elderly: A study of single dose IV administration of diazepam (0.1 mg/kg) indicates that the elimination half-life of diazepam increases linearly with age, ranging from about 15 hours at 18 years (healthy young adults) to about 100 hours at 95 years (healthy elderly) with a corresponding decrease in clearance of free diazepam (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:652714c7-25c4-4d05-979d-8eee3b6f2f4d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Elderly: A study of single dose IV administration of diazepam (0.1 mg/kg) indicates that the elimination half-life of diazepam increases linearly with age, ranging from about 15 hours at 18 years (healthy young adults) to about 100 hours at 95 years (healthy elderly) with a corresponding decrease in clearance of free diazepam ( see PRECAUTIONS and DOSAGE AND ADMINISTRATION ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d99b68aa-b3dc-49c8-8894-3da255cd26b0 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Elderly: A study of single dose IV administration of diazepam (0.1 mg/kg) indicates that the elimination half-life of diazepam increases linearly with age, ranging from about 15 hours at 18 years (healthy young adults) to about 100 hours at 95 years (healthy elderly) with a corresponding decrease in clearance of free diazepam (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5b17a28-2cab-4c0d-8f9d-7b224e4d0989 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Elderly: A study of single dose IV administration of diazepam (0.1 mg/kg) indicates that the elimination half-life of diazepam increases linearly with age, ranging from about 15 hours at 18 years (healthy young adults) to about 100 hours at 95 years (healthy elderly) with a corresponding decrease in clearance of free diazepam ( see PRECAUTIONS and DOSAGE AND ADMINISTRATION ).
Projected row 419
- Medicine slug
- diazepam
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 89
- Source count
- 61
- Agreement rate
- 1
- Recorded readings
98%
- Numeric value
- 98
- Unit
- %
- Source records
- 61
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 61 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:078bbb41-7e3a-48db-87f0-ec6a6ec0194e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8d26f65-a015-4bfc-b1fa-8595d72af48c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9424ce71-f04c-4d70-89de-b7858931c53d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22688087-27ad-620c-e063-6394a90a134c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b326c66d-5762-4d16-933c-619fa2088ccd (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2768add-5e01-4ff4-afa3-230380d59a1f (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01f04ee4-fff9-499a-8213-984e16368084 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ebef149-1858-4199-aaed-7b9341fae63d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32e7bfa1-6060-4041-a0e5-249cacb84ebc (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec433be5-d84d-425f-9edf-71263f885eec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8e4d5f5-3b4c-4c0f-a818-9da86389473c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2fc6f38-d627-4fb3-9be2-5e119ee7e1e1 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e85abed-1a8b-4762-a31f-f2c7f196b8af (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba953b22-f0cd-4be5-9e0e-178bded88727 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:83c1f93b-0fc6-4512-9c8f-9167b217d7f9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:632d7e96-d32c-45b8-86cf-f18ec2b35485 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b47dc708-e83b-4224-bdb5-c9b7abd35cfb (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b51f4b3-a5e8-4400-b624-ac0c47630c86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7646785b-dabc-482d-bf42-06177f00aca2 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dcbb5e9-1e8f-4069-9244-adb46356714d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04cc10ad-7d5c-434e-9b29-85b14071492b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87b0fbb9-0c05-4ab0-8efe-7ffcae85b868 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78d5a77d-5ca7-4f16-b4d0-fce86456593c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84cecab3-d0e6-436b-996b-0b598e972308 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ad84940-40f7-457a-8ffa-53e1a7bfee16 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:181cc7ac-5129-2200-e063-6394a90afd3a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c397a9da-862f-4f3f-8109-7d21691de53a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7a4b3c7-7021-4764-8c21-49e4bc6f6058 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9322b0bc-e9fa-4c89-808b-110decf6db58 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b29916fb-1781-4112-9c3e-45478754d638 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f799120-0d08-47cd-8183-a98f0267c845 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:167ee280-be68-4a28-a7d8-de41df14bc48 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution: Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114ae6e-8cae-e96f-e063-6294a90a9e60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48aa32cb-047a-414a-822e-82a5f26d8817 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb839fb-27e5-4a11-aed6-da0a7ab6e996 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution: Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdb8feda-01c6-45bd-bd66-97196ccce70c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823093aa-d0cd-53c9-e053-2a91aa0a5235 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cb19468-be02-4219-9e80-94a28e2317b9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5111654f-a026-71b2-e063-6294a90ab49b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426f3da1-4105-ba0a-e063-6294a90a7a86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6abedac6-5133-47b2-a0e3-e239e0a2254b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2483426d-3782-432a-8b8d-86c06ef0de4a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20e08b97-bb89-4129-a228-8ad9cf35a1d3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7542d46-2586-4225-b07d-2633116bfa0a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf031ae-d59b-430d-9b15-415ae2e49c98 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b3cc5c9-91bd-7467-e053-2a95a90a44b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:859461ea-5861-8185-e053-2991aa0a954a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:547c2ad4-113c-7771-e063-6394a90a2073 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32c3af91-a57a-1278-e063-6294a90ae5ec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeadf0b0-918b-40e0-a5e8-60b2fcbd5ded (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution: Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b4946b3-ae6c-4174-bbd8-0b8ed2c8fdf3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9a7906-4dca-4c1f-b16b-9b666a86b363 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b24f1eb7-3dab-4183-b81f-f86ac62aedd8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution: Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2047f721-6a05-c391-e063-6394a90a4ed7 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b0c9c0a-4274-4d56-a7a4-bc497916469c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:260e2041-2bb3-482f-850e-b5d47a7bdbe6 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:554baee5-b171-4452-a50a-41a0946f956c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ac0b9d-d4ad-4aaa-8bee-902365f4e9a8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21785bb2-cc96-7973-e063-6294a90ab1b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7002d26-3856-4c2f-e053-2995a90aea60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d322c6a-7f7e-1cc4-e063-6294a90a8e2e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Distribution Diazepam and its metabolites are highly bound to plasma proteins (diazepam 98%).
Projected row 420
- Medicine slug
- diazepam
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 89
- Source count
- 61
- Agreement rate
- 1
- Recorded readings
1 to 1.5 hours
- Numeric value
- 1
- Unit
- hours
- Source records
- 61
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 61 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:078bbb41-7e3a-48db-87f0-ec6a6ec0194e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8d26f65-a015-4bfc-b1fa-8595d72af48c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9424ce71-f04c-4d70-89de-b7858931c53d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22688087-27ad-620c-e063-6394a90a134c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b326c66d-5762-4d16-933c-619fa2088ccd (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2768add-5e01-4ff4-afa3-230380d59a1f (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01f04ee4-fff9-499a-8213-984e16368084 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ebef149-1858-4199-aaed-7b9341fae63d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32e7bfa1-6060-4041-a0e5-249cacb84ebc (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec433be5-d84d-425f-9edf-71263f885eec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8e4d5f5-3b4c-4c0f-a818-9da86389473c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2fc6f38-d627-4fb3-9be2-5e119ee7e1e1 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e85abed-1a8b-4762-a31f-f2c7f196b8af (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration of diazepam, > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba953b22-f0cd-4be5-9e0e-178bded88727 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:83c1f93b-0fc6-4512-9c8f-9167b217d7f9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:632d7e96-d32c-45b8-86cf-f18ec2b35485 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b47dc708-e83b-4224-bdb5-c9b7abd35cfb (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b51f4b3-a5e8-4400-b624-ac0c47630c86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7646785b-dabc-482d-bf42-06177f00aca2 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dcbb5e9-1e8f-4069-9244-adb46356714d (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04cc10ad-7d5c-434e-9b29-85b14071492b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87b0fbb9-0c05-4ab0-8efe-7ffcae85b868 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78d5a77d-5ca7-4f16-b4d0-fce86456593c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration of diazepam, > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84cecab3-d0e6-436b-996b-0b598e972308 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ad84940-40f7-457a-8ffa-53e1a7bfee16 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:181cc7ac-5129-2200-e063-6394a90afd3a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c397a9da-862f-4f3f-8109-7d21691de53a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7a4b3c7-7021-4764-8c21-49e4bc6f6058 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9322b0bc-e9fa-4c89-808b-110decf6db58 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b29916fb-1781-4112-9c3e-45478754d638 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f799120-0d08-47cd-8183-a98f0267c845 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:167ee280-be68-4a28-a7d8-de41df14bc48 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption: After oral administration of diazepam, > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114ae6e-8cae-e96f-e063-6294a90a9e60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48aa32cb-047a-414a-822e-82a5f26d8817 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb839fb-27e5-4a11-aed6-da0a7ab6e996 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption: After oral administration of diazepam, > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdb8feda-01c6-45bd-bd66-97196ccce70c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823093aa-d0cd-53c9-e053-2a91aa0a5235 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cb19468-be02-4219-9e80-94a28e2317b9 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 – 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5111654f-a026-71b2-e063-6294a90ab49b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426f3da1-4105-ba0a-e063-6294a90a7a86 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6abedac6-5133-47b2-a0e3-e239e0a2254b (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2483426d-3782-432a-8b8d-86c06ef0de4a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20e08b97-bb89-4129-a228-8ad9cf35a1d3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7542d46-2586-4225-b07d-2633116bfa0a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cf031ae-d59b-430d-9b15-415ae2e49c98 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b3cc5c9-91bd-7467-e053-2a95a90a44b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:859461ea-5861-8185-e053-2991aa0a954a (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:547c2ad4-113c-7771-e063-6394a90a2073 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32c3af91-a57a-1278-e063-6294a90ae5ec (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeadf0b0-918b-40e0-a5e8-60b2fcbd5ded (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption: After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b4946b3-ae6c-4174-bbd8-0b8ed2c8fdf3 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9a7906-4dca-4c1f-b16b-9b666a86b363 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b24f1eb7-3dab-4183-b81f-f86ac62aedd8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption: After oral administration of diazepam, > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2047f721-6a05-c391-e063-6394a90a4ed7 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b0c9c0a-4274-4d56-a7a4-bc497916469c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:260e2041-2bb3-482f-850e-b5d47a7bdbe6 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 – 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:554baee5-b171-4452-a50a-41a0946f956c (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 – 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ac0b9d-d4ad-4aaa-8bee-902365f4e9a8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 – 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21785bb2-cc96-7973-e063-6294a90ab1b8 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7002d26-3856-4c2f-e053-2995a90aea60 (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration >90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1 to 1.5 hours with a range of 0.25 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d322c6a-7f7e-1cc4-e063-6294a90a8e2e (opens source in a new tab)
Diazepam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption After oral administration > 90% of diazepam is absorbed and the average time to achieve peak plasma concentrations is 1-1.5 hours with a range of 0.25 to 2.5 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=410Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.